Advertisement

Anemia in the Patient with Chronic Lung Disease

  • Tim J. McMahon
  • Ann C. Prybylowski
Chapter

Abstract

Chronic lung disease is sometimes associated with erythrocytosis, especially when chronic hypoxemia is present. Anemia, even in the presence of hypoxemia, is also relatively common in chronic lung diseases, such as chronic obstructive pulmonary disease (COPD). Recognizing anemia in these patients is essential as anemia may exacerbate symptoms of dyspnea, limit patients’ functioning, raise health care costs, and worsen overall prognosis. The most common type of anemia in chronic lung disease is anemia of chronic disease (ACD). Identifying other types or causes of anemia in the patient with chronic lung disease is critical because treatment of the underlying lung disease remains unsatisfactory in lung diseases like emphysema, chronic bronchitis, idiopathic pulmonary fibrosis, and cystic fibrosis. After describing some of the unique factors driving ACD as well as other causes of anemia in patients with chronic lung disease, we will review the available evidence on which to base decisions concerning anemia management in this population.

Keywords

Anemia Anemia of chronic disease Asthma Chronic obstructive pulmonary disease (COPD) Cystic fibrosis Emphysema Hypoxemia Iron-deficiency anemia Pulmonary fibrosis Pulmonary arterial hypertension 

Notes

Acknowledgments

The authors thank Dan Gilstrap, MD for an expert literature search that aided in constructing this chapter, and Amy Loeblein for expert editorial work. Research funds from VA (I01-BX-003478 to TJM) and NIH (GM-113838 to TJM) helped support this work.

References

  1. 1.
    Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care. 2011;56(5):644–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Mannino DM, Higuchi K, Yu TC, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138–50.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128(3):1201–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Cappell MS, Nadler SC. Increased mortality of acute upper gastrointestinal bleeding in patients with chronic obstructive pulmonary disease. A case controlled, multiyear study of 53 consecutive patients. Dig Dis Sci. 1995;40(2):256–62.CrossRefPubMedGoogle Scholar
  5. 5.
    Upchurch GR Jr, Proctor MC, Henke PK, et al. Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease. J Vasc Surg. 2003;37(3):594–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Kollert F, Tippelt A, Muller C, et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care. 2013;58(7):1204–12.CrossRefPubMedGoogle Scholar
  7. 7.
    Drury KE, Schaeffer M, Silverberg JI. Association between atopic disease and anemia in US children. JAMA Pediatr. 2016;170(1):29–34.CrossRefPubMedGoogle Scholar
  8. 8.
    Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42(12):1193–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Hoo ZH, Wildman MJ. Intravenous iron among cystic fibrosis patients. J Cyst Fibros. 2012;11(6):560–2.CrossRefPubMedGoogle Scholar
  10. 10.
    Ruiter G, Lankhorst S, Boonstra A, et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J. 2011;37(6):1386–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Cotroneo E, Ashek A, Wang L, et al. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Circ Res. 2015;116(10):1680–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Crawford J. Anemia and lung cancer. Lung Cancer. 2002;38(Suppl 3):S75–8.CrossRefPubMedGoogle Scholar
  13. 13.
    AMGEN. ORTHO BIOTECH. Additional Trials Showing Increased Mortality and/or Tumor Progression with EPOGEN®/PROCRIT® and Aranesp®. http://www.fda.gov/downloads/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm126604.pdf. Accessed 15 Sep 2016.
  14. 14.
    Waters JS, O’Brien ME, Ashley S. Management of anemia in patients receiving chemotherapy. J Clin Oncol. 2002;20(2):601–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Holgersson G, Sandelin M, Hoye E, et al. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol. 2012;29(5):3176–82.CrossRefPubMedGoogle Scholar
  16. 16.
    Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886–95.CrossRefPubMedGoogle Scholar
  17. 17.
    Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134(1):109–15.CrossRefPubMedGoogle Scholar
  18. 18.
    DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):699–710.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Beverung LM, Strouse JJ, Hulbert ML, et al. Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. Am J Hematol. 2015;90(2):139–43.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med. 1999;340(6):409–17.CrossRefPubMedGoogle Scholar
  21. 21.
    Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609–19.CrossRefPubMedGoogle Scholar
  22. 22.
    Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229–39.CrossRefPubMedGoogle Scholar
  23. 23.
    Koch C, Li L, Figueroa P, Mihaljevic T, Svensson L, Blackstone EH. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg. 2009;88(5):1410–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Glynn SA. Blood supply safety: an NHLBI perspective. Transfusion. 2008;48(8):1541–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Steiner ME, Stowell C. Does red blood cell storage affect clinical outcome? When in doubt, do the experiment. Transfusion. 2009;49(7):1286–90.CrossRefPubMedGoogle Scholar
  26. 26.
    Lacroix J, Hebert PC, Fergusson DA, et al. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Fergusson DA, Hebert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012;308(14):1443–51.CrossRefPubMedGoogle Scholar
  28. 28.
    Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372(15):1419–29.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med. 1998;26(11):1824–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Schonhofer B, Bohrer H, Kohler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia. 1998;53(2):181–4.CrossRefPubMedGoogle Scholar
  31. 31.
    Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49–58.CrossRefPubMedGoogle Scholar
  32. 32.
    Cassat JE, Skaar EP. Iron in infection and immunity. Cell Host Microbe. 2013;13(5):509–19.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Department of MedicineDuke University and Durham VA Medical CentersDurhamUSA
  2. 2.Duke University and University of Pennsylvania Medical CentersPhiladelphiaUSA

Personalised recommendations